Vivesto AB (STO:VIVE)
Sweden · Delayed Price · Currency is SEK 0.0818
+0.0034 (4.34%)
Apr 14, 2026, 5:29 PM CET
Vivesto AB Market Cap
Vivesto AB has a market cap or net worth of 90.56 million as of April 14, 2026. Its market cap has decreased by -29.72% in one year.
Market Cap
90.56M
Enterprise Value
88.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since August 11, 2006, Vivesto AB's market cap has decreased from 1.15B to 90.56M, a decrease of -92.13%. That is a compound annual growth rate of -12.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 90.56M | 24.68% |
| Dec 30, 2025 | 72.64M | -53.45% |
| Dec 30, 2024 | 156.03M | -28.83% |
| Dec 29, 2023 | 219.25M | -6.11% |
| Dec 30, 2022 | 233.51M | -80.14% |
| Dec 30, 2021 | 1.18B | -36.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.64B |
| Dicot Pharma AB | 784.45M |
| Cinclus Pharma Holding AB | 767.87M |
| Enzymatica AB | 716.07M |
| Orexo AB | 710.66M |
| Nanexa AB | 662.45M |
| Moberg Pharma AB | 472.83M |
| Klaria Pharma Holding AB (publ.) | 281.40M |